Skip to content
Home/Companies/Biotech/SynAct Pharma

SynAct Pharma

Biotech·Denmark·Exited 2016·Held 4yr
Entry
2012
Hold
4yr
Exit
2016

Who owns SynAct Pharma?

SynAct Pharma is a Danish Biotech company, formerly owned by Capnova, exited in 2016 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Capnova
Investor
Capnova
CAPNOVA · 1998 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2016

More from CAPNOVA

Other portfolio companies in the same fund.

Triband
Exited 2020
GamingDenmark· 2016
to Triband ApS
SYBO Games
Exited 2012
GamingDenmark· 2011
Action Pharma
Exited 2012
BiotechDenmark· 2002
to Abbott
MediConnect
Exited 2005
HealthTechDenmark· 2001
to Kommuneinformation A/S (now part of EG)
Aros Applied Biotechnology
Exited 2013
BiotechDenmark· 2000
to Eurofins

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns SynAct Pharma?

SynAct Pharma was formerly owned by Capnova, exited in 2016. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue